Advertisement

Dendritic cells pulsed with malondialdehyde modified low density lipoprotein aggravate atherosclerosis in Apoe−/− mice

      Abstract

      Objective

      Atherosclerosis is an inflammatory disease involving activation of adaptive and innate immune responses to modified lipoproteins. Dendritic cells (DCs), which are professional antigen-presenting cells that activate T cells, are present in atherosclerotic lesions but their role for atherosclerosis-related immunity is unclear.

      Methods and results

      To evaluate the role of DC in atherosclerosis, DCs pulsed with malondialdehyde modified low density lipoprotein (MDA-LDL) were transferred into Apoe−/− mice. The extent of disease was measured in the aortic root and was compared to that in animals treated with Keyhole Limpet Hemocyanin (KLH) pulsed DCs and to untreated animals. Mice receiving MDA-LDL pulsed DCs showed significantly larger atherosclerotic lesions compared to controls, with increased inflammation in the lesions and antigen-specific immune responses. Furthermore, MDA-LDL administration in complete Freund's adjuvant, which is atheroprotective, led to the induction of regulatory T cells whereas MDA-LDL-DCs treatment did not, suggesting that modulation of immune properties can result in different effects on atherosclerosis.

      Conclusions

      DCs presenting components of LDL promote specific immunity to their antigen, increase lesion inflammation and accelerate atherosclerosis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hansson G.K.
        Inflammation, atherosclerosis, and coronary artery disease.
        N Engl J Med. 2005; 352: 1685-1695
        • Binder C.J.
        • Chang M.K.
        • Shaw P.X.
        • et al.
        Innate and acquired immunity in atherogenesis.
        Nat Med. 2002; 8: 1218-1226
        • Hansson G.K.
        • Libby P.
        The immune response in atherosclerosis: a double-edged sword.
        Nat Rev Immunol. 2006; 6: 508-519
        • Yla-Herttuala S.
        • Palinski W.
        • Butler S.W.
        • Picard S.
        • Steinberg D.
        • Witztum J.L.
        Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.
        Arterioscler Thromb. 1994; 14: 32-40
        • Stemme S.
        • Faber B.
        • Holm J.
        • Wiklund O.
        • Witztum J.L.
        • Hansson G.K.
        T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.
        Proc Natl Acad Sci USA. 1995; 92: 3893-3897
        • Zhou X.
        • Robertson A.K.
        • Hjerpe C.
        • Hansson G.K.
        Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis.
        Arterioscler Thromb Vasc Biol. 2006; 26: 864-870
        • Ait-Oufella H.
        • Salomon B.L.
        • Potteaux S.
        • et al.
        Natural regulatory T cells control the development of atherosclerosis in mice.
        Nat Med. 2006; 12: 178-180
        • Lord R.S.
        • Bobryshev Y.V.
        Clustering of dendritic cells in athero-prone areas of the aorta.
        Atherosclerosis. 1999; 146: 197-198
        • Bobryshev Y.V.
        • Taksir T.
        • Lord R.S.
        • Freeman M.W.
        Evidence that dendritic cells infiltrate atherosclerotic lesions in apolipoprotein E-deficient mice.
        Histol Histopathol. 2001; 16: 801-808
        • Choi J.H.
        • Do Y.
        • Cheong C.
        • et al.
        Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves.
        J Exp Med. 2009; 206: 497-505
        • Son Y.I.
        • Egawa S.
        • Tatsumi T.
        • Redlinger Jr., R.E.
        • Kalinski P.
        • Kanto T.
        A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells.
        J Immunol Methods. 2002; 262: 145-157
        • Palinski W.
        • Tangirala R.K.
        • Miller E.
        • Young S.G.
        • Witztum J.L.
        Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis.
        Arterioscler Thromb Vasc Biol. 1995; 15: 1569-1576
        • Zhou X.
        • Caligiuri G.
        • Hamsten A.
        • Lefvert A.K.
        • Hansson G.K.
        LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis.
        Arterioscler Thromb Vasc Biol. 2001; 21: 108-114
        • Ingulli E.
        • Mondino A.
        • Khoruts A.
        • Jenkins M.K.
        In vivo detection of dendritic cell antigen presentation to CD4(+) T cells.
        J Exp Med. 1997; 185: 2133-2141
        • Angeli V.
        • Llodra J.
        • Rong J.X.
        • et al.
        Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization.
        Immunity. 2004; 21: 561-574
        • Ludewig B.
        • Freigang S.
        • Jaggi M.
        • et al.
        Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model.
        Proc Natl Acad Sci USA. 2000; 97: 12752-12757
        • t Hart B.A.
        • van Kooyk Y.
        Yin-Yang regulation of autoimmunity by DCs.
        Trends Immunol. 2004; 25: 353-359
        • Verginis P.
        • Li H.S.
        • Carayanniotis G.
        Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells.
        J Immunol. 2005; 174: 7433-7439